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Colorectal cancer is the third most common malignant neoplasm worldwide, 
predominantly affecting the elderly population. However, in recent decades, 
there has been an increase in its incidence in patients under 50 years of age, 
who currently represent 7-26% of the diagnosed cases1-3.
In this age group, the clinical presentation is similar to that of patients over 
50. A previous prevalence study with young patients showed that the most 
common symptoms are rectal bleeding (57%), abdominal pain (31%), change 
in bowel habits (21%), weight loss (11%), and anemia (11%)1.
Younger patients present a clinically more advanced and biologically more 
aggressive disease. The most commonly found histologic type is mucinous 
adenocarcinoma with poorly differentiated signet ring cells1,3-5. A retrospective 
review involving 180 patients younger than 50 years showed that, at the time 
of diagnosis, 37 (21%) patients were in stage I, 47 (26%) in stage II, 70 (39%) 
in stage III, and 26 (14%) in stage IV1.
The majority of cases are sporadic tumors, as much in younger patients 
as in older; however, mutation analysis of younger patients, particularly for 
Lynch syndrome, the most common form of hereditary colorectal cancer, 
should be performed.
In this report, we present the case of a patient diagnosed with colorectal 
cancer at the age of 17. Cases like this are rare in the literature; however, 
they support the statistics that show an increase in the incidence of this type 
of cancer in young patients.
CASE REPORT
A 17-year-old male patient, born and raised in Porto Alegre, arrived at 
the emergency room of Hospital de Clínicas de Porto Alegre complaining 
of abdominal pain and distension associated with nausea and vomiting 
for 1 month, weight loss (5 kg in 1 month), and diarrhea for 5 days without 
associated pathology. There was no family history of colorectal cancer. 
The patient was an alcoholic (1 L of vodka/day) for 1 year and a daily user 
of marijuana. Physical examination revealed a body mass index of 16 kg/m2, 
distended abdomen, and shifting dullness but with no other abnormalities.
Laboratory tests showed normocytic and normochromic anemia. Serological 
tests for HIV and hepatitis B and C were negative.
Abdominal ultrasound confirmed voluminous ascites without changes in 
structure or hepatic vessel flow. Paracentesis was performed and 3.7 L of a 
citrine-colored liquid were removed. Cellularity was lymphocyte predominant 
and cytopathology was negative.
Computed tomography (CT) of abdomen was performed and identified 
a 5.9 cm-long stenotic lesion in transverse colon causing upstream colonic 
distension; thickening of the ileocecal valve and of the walls of the terminal 
ileum; ileal and jejunal distension; and densification of greater omentum, 
transverse mesocolon and parietal peritoneum associated with ascites (figure 1).
Colonoscopy revealed a vegetating intraluminal lesion occupying 95% of 
the transverse colon cavity. Biopsies gave a histopathological diagnosis of 
ulcerated adenocarcinoma with poorly differentiated signet ring cells (figure 2).
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Figure 2: Infiltrative lesion in transverse colon.
Figure 1: Computed tomographic with stenotic lesion in transverse colon.
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Two days later, the patient developed intestinal 
obstruction and underwent an emergency laparotomy, 
right ileocolectomy, and ileocolic anastomosis. 
Among the operative findings there were ascites 
(3200 mL), tumor in the proximal transverse colon with 
thickening of the omentum, invasion of the greater 
gastric curvature, and peritoneal carcinomatosis. 
Pathological examination confirmed synchronous 
adenocarcinoma of ascending and transverse colon with 
metastases to cecal appendix and four lymph nodes, 
corresponding to surgical stage T4N2M1 (stage IV). 
A search for Lynch syndrome with mismatch repair 
immunohistochemistry of microsatellite instability of 
high-frequency MSH1, MSH2, MSH6, and PMS2 
was negative. Chest CT was performed and showed 
no evidence of metastasis. Patient exhibited good 
postoperative evolution and after 1 month, at ECOG 
performance status 0, underwent eight cycles of 
FOLFOX chemotherapy. Later there was progression 
of the disease: an increase in abdominal damage and 
intestinal obstruction, which led to death 7 months 
after diagnosis.
DISCUSSION
Colorectal cancer in patients younger than 30 years 
old corresponds to 1-2% of cases. Biologically, the 
disease seems to be more aggressive in young patients 
and 61.8% are in an advanced stage (stages III / IV) 
at the time of diagnosis. However, there seems to 
be no difference in survival when compared to older 
adults, probably because the younger population 
has fewer comorbidities and better performance 
in and tolerance to treatments3,4,6. Higher rates of 
peritoneal carcinosis as well as larger (> 5 cm) and 
more infiltrative tumors are also reported in younger 
patients5.
Although most cases of colorectal neoplasia are 
sporadic, in this age group there is a greater incidence of 
gene mutations and genetic evaluation is recommended 
for Lynch syndrome by searching for microsatellite 
instability or examining immunohistochemistry for 
the presence of DNA repair proteins (MSH1, MSH2, 
MSH6, and PMS2). The diagnosis of colorectal 
cancer in these patients modifies the follow-up 
of first-degree relatives7,8. A study comparing the 
presence of mutated Kirsten Ras (KRAS), BRAF, 
and MSI (microsatellite instability) genes, which may 
be associated with aggressive disease and in some 
cases provide information for treatment purposes, 
between patient groups under and over 40 years of age 
showed no statistically significant difference between 
the groups6. In the present case, colonoscopy did not 
reveal polyps or other findings indicative of familial 
adenomatous polyposis or inflammatory diseases. 
Work-up for Lynch syndrome was negative. Testing 
for KRAS and BRAF mutation was not performed.
Currently, there is a decrease in the incidence of 
colorectal cancer in patients older than 50 and an 
increase in incidence in those younger than 50. This is 
probably related to screening of elderly patients, 
which makes the treatment of premalignant lesions 
possible at an earlier stage. The diagnosis in young 
people is often late since neoplasia is rarer in this 
age group and the symptoms tend to be attributed 
to benign pathologies. In light of the foregoing, it is 
necessary to pay close attention to symptoms in this 
population and conduct new studies to evaluate the 
possible benefits of performing early screening3,5-11.
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